• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将 ELSI 研究问题纳入新生儿筛查试点研究中。

Including ELSI research questions in newborn screening pilot studies.

机构信息

Department of Bioethics, Center for Genetic Research Ethics and Law, Case Western Reserve University, Cleveland, Ohio, USA.

Parent Project Muscular Dystrophy, Hackensack, New Jersey, USA.

出版信息

Genet Med. 2019 Mar;21(3):525-533. doi: 10.1038/s41436-018-0101-x. Epub 2018 Aug 13.

DOI:10.1038/s41436-018-0101-x
PMID:30100612
Abstract

BACKGROUND

The evidence review processes for adding new conditions to state newborn screening (NBS) panels rely on data from pilot studies aimed at assessing the potential benefits and harms of screening. However, the consideration of ethical, legal, and social implications (ELSI) of screening within this research has been limited. This paper outlines important ELSI issues related to newborn screening policy and practices as a resource to help researchers integrate ELSI into NBS pilot studies.

APPROACH

Members of the Bioethics and Legal Workgroup for the Newborn Screening Translational Research Network facilitated a series of professional and public discussions aimed at engaging NBS stakeholders to identify important existing and emerging ELSI challenges accompanying NBS.

RESULTS

Through these engagement activities, we identified a set of key ELSI questions related to (1) the types of results parents may receive through newborn screening and (2) the initiation and implementation of NBS for a condition within the NBS system.

CONCLUSION

Integrating ELSI questions into pilot studies will help NBS programs to better understand the potential impact of screening for a new condition on newborns and families, and make crucial policy decisions aimed at maximized benefits and mitigating the potential negative medical or social implications of screening.

摘要

背景

将新条件添加到州新生儿筛查 (NBS) 计划中,其证据审查过程依赖于旨在评估筛查潜在益处和危害的试点研究数据。然而,在这项研究中,对筛查的伦理、法律和社会影响 (ELSI) 的考虑是有限的。本文概述了与新生儿筛查政策和实践相关的重要 ELSI 问题,作为帮助研究人员将 ELSI 纳入 NBS 试点研究的资源。

方法

新生儿筛查转化研究网络的伦理和法律工作组的成员促进了一系列专业和公众讨论,旨在让 NBS 利益相关者参与,以确定伴随 NBS 的现有和新出现的 ELSI 挑战。

结果

通过这些参与活动,我们确定了一系列与 (1) 父母可能通过新生儿筛查获得的结果类型和 (2) 在 NBS 系统中对某一条件启动和实施 NBS 相关的关键 ELSI 问题。

结论

将 ELSI 问题纳入试点研究将帮助 NBS 计划更好地了解筛查新条件对新生儿和家庭的潜在影响,并做出旨在最大限度地提高效益和减轻筛查潜在负面医疗或社会影响的关键政策决策。

相似文献

1
Including ELSI research questions in newborn screening pilot studies.将 ELSI 研究问题纳入新生儿筛查试点研究中。
Genet Med. 2019 Mar;21(3):525-533. doi: 10.1038/s41436-018-0101-x. Epub 2018 Aug 13.
2
Charting the Ethical Frontier in Newborn Screening Research: Insights from the NBSTRN ELSI Researcher Needs Survey.绘制新生儿筛查研究中的伦理前沿:来自新生儿筛查转化研究网络(NBSTRN)伦理、法律与社会问题(ELSI)研究者需求调查的见解
Int J Neonatal Screen. 2024 Sep 19;10(3):64. doi: 10.3390/ijns10030064.
3
Parental permission for pilot newborn screening research: guidelines from the NBSTRN.新生儿筛查研究中获得父母同意的指导原则:NBSTRN 指南。
Pediatrics. 2014 Feb;133(2):e410-7. doi: 10.1542/peds.2013-2271. Epub 2014 Jan 6.
4
Newborn screening by tandem mass spectrometry: ethical and social issues.串联质谱新生儿筛查:伦理与社会问题
Can J Public Health. 2007 Jul-Aug;98(4):284-6. doi: 10.1007/BF03405404.
5
ScreenPlus: A comprehensive, multi-disorder newborn screening program.ScreenPlus:一项全面的多病症新生儿筛查计划。
Mol Genet Metab Rep. 2023 Dec 14;38:101037. doi: 10.1016/j.ymgmr.2023.101037. eCollection 2024 Mar.
6
NBSTRN Tools to Advance Newborn Screening Research and Support Newborn Screening Stakeholders.推进新生儿筛查研究及支持新生儿筛查利益相关者的工具。
Int J Neonatal Screen. 2023 Oct 30;9(4):63. doi: 10.3390/ijns9040063.
7
Challenges and opportunities for ELSI early career researchers.ELSI领域早期职业研究人员面临的挑战与机遇。
BMC Med Ethics. 2016 Jul 8;17(1):37. doi: 10.1186/s12910-016-0121-5.
8
Foundation of the Newborn Screening Translational Research Network and its tools for research.新生儿筛查转化研究网络及其研究工具的基础。
Genet Med. 2019 Jun;21(6):1271-1279. doi: 10.1038/s41436-018-0334-8. Epub 2018 Nov 5.
9
Ethical, Legal, and Social Implications (ELSI) Research: Methods and Approaches.伦理、法律和社会影响(ELSI)研究:方法与途径。
Curr Protoc. 2022 Jan;2(1):e354. doi: 10.1002/cpz1.354.
10
Preparing newborn screening for the future: a collaborative stakeholder engagement exploring challenges and opportunities to modernizing the newborn screening system.为未来做好新生儿筛查准备:合作利益相关者参与探索现代化新生儿筛查系统所面临的挑战和机遇。
BMC Pediatr. 2022 Feb 12;22(1):90. doi: 10.1186/s12887-021-03035-x.

引用本文的文献

1
Charting the Ethical Frontier in Newborn Screening Research: Insights from the NBSTRN ELSI Researcher Needs Survey.绘制新生儿筛查研究中的伦理前沿:来自新生儿筛查转化研究网络(NBSTRN)伦理、法律与社会问题(ELSI)研究者需求调查的见解
Int J Neonatal Screen. 2024 Sep 19;10(3):64. doi: 10.3390/ijns10030064.
2
Future of Dutch NGS-Based Newborn Screening: Exploring the Technical Possibilities and Assessment of a Variant Classification Strategy.荷兰基于下一代测序技术的新生儿筛查的未来:探索技术可能性及变异分类策略评估
Int J Neonatal Screen. 2024 Mar 7;10(1):20. doi: 10.3390/ijns10010020.
3
ScreenPlus: A comprehensive, multi-disorder newborn screening program.

本文引用的文献

1
Mandatory versus voluntary consent for newborn screening?新生儿筛查强制同意与自愿同意?
Kennedy Inst Ethics J. 2010 Dec;20(4):299-328.
ScreenPlus:一项全面的多病症新生儿筛查计划。
Mol Genet Metab Rep. 2023 Dec 14;38:101037. doi: 10.1016/j.ymgmr.2023.101037. eCollection 2024 Mar.
4
NBSTRN Tools to Advance Newborn Screening Research and Support Newborn Screening Stakeholders.推进新生儿筛查研究及支持新生儿筛查利益相关者的工具。
Int J Neonatal Screen. 2023 Oct 30;9(4):63. doi: 10.3390/ijns9040063.
5
Is Our Newborn Screening Working Well? A Literature Review of Quality Requirements for Newborn Blood Spot Screening (NBS) Infrastructure and Procedures.我们的新生儿筛查工作进展顺利吗?新生儿血斑筛查(NBS)基础设施与程序质量要求的文献综述。
Int J Neonatal Screen. 2023 Jun 22;9(3):35. doi: 10.3390/ijns9030035.
6
Genomic-Based Newborn Screening for Inborn Errors of Immunity: Practical and Ethical Considerations.基于基因组学的新生儿免疫缺陷病筛查:实际与伦理考量
Int J Neonatal Screen. 2023 Apr 11;9(2):22. doi: 10.3390/ijns9020022.
7
When is the best time to screen and evaluate for treatable genetic disorders?: A lifespan perspective.何时是筛查和评估可治疗遗传疾病的最佳时机?:从寿命角度看。
Am J Med Genet C Semin Med Genet. 2023 Mar;193(1):44-55. doi: 10.1002/ajmg.c.32036. Epub 2023 Mar 6.
8
Newborn screening research sponsored by the NIH: From diagnostic paradigms to precision therapeutics.美国国立卫生研究院资助的新生儿筛查研究:从诊断范式到精准治疗。
Am J Med Genet C Semin Med Genet. 2022 Jun;190(2):138-152. doi: 10.1002/ajmg.c.31997. Epub 2022 Sep 14.
9
The Progress and Future of US Newborn Screening.美国新生儿筛查的进展与未来
Int J Neonatal Screen. 2022 Jul 18;8(3):41. doi: 10.3390/ijns8030041.
10
Barriers and Facilitators for Population Genetic Screening in Healthy Populations: A Systematic Review.健康人群中群体遗传筛查的障碍与促进因素:一项系统综述
Front Genet. 2022 Jul 4;13:865384. doi: 10.3389/fgene.2022.865384. eCollection 2022.